Inflammation, immunity and vaccines for Helicobacter pylori

Helicobacter

Volumn 9, Issue SUPPL. 1, 2004, Pages 23-28

  Del Giudice, Giuseppe ^a   Michetti, Pierre ^b  

^a Research Center   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Cytokines; Inflammation; Regulatory lymphocytes; T lymphocytes; Vaccines

Indexed keywords

ANTIGEN; BACTERIAL TOXIN; CYTOKINE; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; VIRULENCE FACTOR;

ATROPHIC GASTRITIS; CHRONIC GASTRITIS; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; HELICOBACTER INFECTION; HOST; HUMAN; IMMUNE RESPONSE; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TISSUE INDUCTION;

ANIMALS; BACTERIAL VACCINES; CYTOKINES; GASTRITIS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY; INFLAMMATION; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 4644257423     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1083-4389.2004.00245.x     Document Type: Review

References (38)

1. Rad R, Prinz C, Neu B, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003;188:272-81.
2. Rollinson S, Levene AP, Mensah FK, et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 2003;102:1007-11.
3. Hamajima N, Katsuda N, Matsuo K, et al. High anti-Helicobacter pylori antibody seropositivity associated with the combination of IL-8-251TT and IL-10-;819TT: genotypes. Helicobacter 2003;8:105-10.
4. Orsini B, Ottanelli B, Amedei A, et al. Helicobacter pylori cag pathogenicity island is associated with reduced expression of interleukin-4 (IL-4) mRNA and modulation of the IL-4delta2 mRNA isoform in human gastric mucosa. Infect Immun 2003;71:6664-7.
5. Monteleone G, Del Vecchio Blanco G, Palmieri G, et al. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology 2004;126:674-82.
6. Karita M, Matsumoto S, Kamei T. The size of cagA based on repeat sequence has the responsibility of the location of Helicobacter pylori in the gastric mucus and the degree of gastric mucosal inflammation. Microbiol Immunol 2003;47:619-30.
7. Mori N, Sato H, Hayashibara T, et al. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. Gastroenterology 2003;124:983-92.
8. Bebb JR, Letley DP, Thomas RJ, et al. Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner. Gut 2003;52:1408-13.
9. Tran CD, Huynh H, van den Berg M, et al. Helicobacter-induced gastritis in mice not expressing metallothionein-I and II. Helicobacter 2003;8:533-41.
10. Obonyo M, Guiney DG, Fierer J, et al. Interactions between inducible nitric oxide and other inflammatory mediators during Helicobacter pylori infection. Helicobacter 2003;8:495-502.
11. Giamarellos-Bourboulis EJ, Tzivras M, Kourtesas D, et al. Lipid peroxidation in chronic gastritis; any influence of Helicobacter pylori? Prostaglandins Leukot Essent Fatty Acids 2003;68:257-61.
12. Guiney DG, Hasegawa P, Cole SP. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect Immun 2003;71:4163-6.
13. Hoffman PS, Vats N, Hutchison D, et al. Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori. Infect Immun 2003;71:2534-41.
14. Holck S, Norgaard A, Bennedsen M, et al. Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunol Med Microbiol 2003;36:175-80.
15. Zavros Y, Rathinavelu S, Kao JY, et al. Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci USA 2003;100:12944-9.
16. Ceponis PJ, McKay DM, Menaker RJ, et al. Helicobacter pylori infection interferes with epithelial Stat6-mediated interleukin-4 signal transduction independent of cagA, cagE, or VacA. J Immunol 2003;171:2035-41.
17. Watanabe K, Murakami K, Sato R, et al. CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice. Clin Exp Immunol 2004;135:29-34.
18. Ismail HF, Fick P, Zhang J, et al. Depletion of neutrophils in IL-10 (-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 2003;170:3782-9.
19. Ismail HF, Zhang J, Lynch RG, et al. Role for complement in development of Helicobacter-induced gastritis in interleukin-10-deficient mice. Infect Immun 2003;71:7140-8.
20. Sommer F, Wilken H, Faller G, et al. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis. Infect Immun 2004;72:1029-35.
21. Raghavan S, Nystrom J, Fredriksson M, et al. Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection. Infect Immun 2003;71:7014-22.
22. Garhart CA, Nedrud JG, Heinzel FP, et al. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun 2003;71:3628-33.
23. Garhart CA, Heinzel FP, Czinn SJ, et al. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect Immun 2003;71:910-21.
24. Panthel K, Faller G, Haas R. Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect Immun 2003;71:794-800.
25. Mueller A, O'Rourke J, Chu P, et al. Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci USA 2003;100:12289-94.
26. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002;16:67-76.
27. high regulatory T cells suppress memory T-cell responses to Helicobacter pylori in infected individuals. Infect Immun 2003;71:1755-62.
28. Raghavan S, Fredriksson M, Svennerholm AM, et al. Absence of CD4+ CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter-infected mice. Clin Exp Immunol 2003;132:393-400.
29. Montecucco C, de Bernard M. Immunosuppressive and proinflammatory activities of the VacA toxin of Helicobacter pylori. J Exp Med 2003;198:1767-71.
30. Gebert B, Fischer W, Weiss E, et al. Helicobacter pylon vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003;301:1099-102.
31. Boncristiano M, Paccani SR, Barone S, et al. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med 2003;198:1887-97.
32. Ruggiero P, Peppoloni S, Rappuoli R, et al. The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? Microbes Infect 2003;5:749-56.
33. Vajdy M, Singh M, Ugozzoli M, et al. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations. Immunology 2003;110:86-94.
34. Johansson EL, Bergquist C, Edebo A, et al. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach. Vaccine 2004;22:984-90.
35. Losonsky GA, Kotloff KL, Walker RI. B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT (R192G) in H. pylori seronegative individuals. Vaccine 2003;21:562-5.
36. Frenck RW Jr, Clemens J. Helicobacter in the developing world. Microbes Infect 2003;5:705-13.
37. Corthesy-Theulaz I, Corthesy B, Bachmann D, et al. Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning. Infect Immun 2003;71:2226-9.
38. Eisenberg JC, Czinn SJ, Garhart CA, et al. Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice. Infect Immun 2003;71:1820-7.